Market Research Logo

Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review

Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Noevir Holdings Co., Ltd. (Noevir Holdings), through its subsidiaries manufactures and markets skincare, pharmaceuticals and health food products. The company offers various skin care products such as beauty serums, face and body moisturizers, creams and lotions, moisturizing sheet mask, moisturizing gels, complete cleansing line including cleansing cream, cleansing milk, cleansing water and cleansing mouse, eye creams and cosmetics such as eye makeup line, blush, foundation and lip makeup line. It also offers cough drops, functional drinks, over the counter (OTC) pharmaceuticals, cold remedies, eye drops and other nutritional supplements. Noevir Holdings markets these products under excel, Noevir, Nameraka Honpo, NOV, Min Min Da Ha and Nanten Nodo Ame. The company merchandises and sells products through various sales channels including drug stores, general retailers, specialty goods stores, general merchandise stores (GMS), supermarkets, and convenience stores at various affordable prices across domestic and international markets. It also offers contract manufacturing cosmetics and quasi-drugs. The company has manufacturing facilities in Kyoto and Iga. Noevir Holdings is headquartered in Tokyo, Japan.

Noevir Holdings Co Ltd Key Recent Developments

Feb 13,2019: Noevir Holdings Announces Consolidated Results for the First Three Months of the Fiscal Year Ending September 30, 2019
Apr 27,2018: Noevir Holdings Announces Consolidated Results for the First Six Months of the Fiscal Year Ending September 30, 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Noevir Holdings Co Ltd - Key Facts
Noevir Holdings Co Ltd - Key Employees
Noevir Holdings Co Ltd - Major Products and Services
Noevir Holdings Co Ltd - History
Noevir Holdings Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Noevir Holdings Co Ltd - Business Description
Business Segment: Cosmetics
Overview
Performance
Key Stats
Business Segment: Other
Overview
Performance
Business Segment: Pharmaceuticals and Health Food
Overview
Performance
Noevir Holdings Co Ltd - Corporate Strategy
Noevir Holdings Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Noevir Holdings Co Ltd - Strengths
Noevir Holdings Co Ltd - Weaknesses
Noevir Holdings Co Ltd - Opportunities
Noevir Holdings Co Ltd - Threats
Noevir Holdings Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
Apr 27, 2018: Noevir Holdings Announces Consolidated Results for the First Six Months of the Fiscal Year Ending September 30, 2018
Section 5 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Noevir Holdings Co Ltd, Key Facts
Noevir Holdings Co Ltd, Key Employees
Noevir Holdings Co Ltd, Major Products and Services
Noevir Holdings Co Ltd, History
Noevir Holdings Co Ltd, Other Locations
Noevir Holdings Co Ltd, Subsidiaries
Noevir Holdings Co Ltd, Key Competitors
Noevir Holdings Co Ltd, Ratios based on current share price
Noevir Holdings Co Ltd, Annual Ratios
Noevir Holdings Co Ltd, Annual Ratios (Cont...1)
Noevir Holdings Co Ltd, Annual Ratios (Cont...2)
Noevir Holdings Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Noevir Holdings Co Ltd, Performance Chart (2014 - 2018)
Noevir Holdings Co Ltd, Ratio Charts

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook